Xavier Morin-Charest
Quebec, QC G1V4G2, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Regulation of the Expression, Oligomerisation and Signaling of the Inhibitory Receptor CLEC12A by Cysteine Residues in the Stalk Region.
Journal: International journal of molecular sciences
Published: August 05, 2021
In Vitro Modeling of Bradykinin-Mediated Angioedema States.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 17, 2020
In Vitro Pharmacological Profile of a New Small Molecule Bradykinin B2 Receptor Antagonist.
Journal: Frontiers in pharmacology
Published: March 16, 2020
Bradykinin receptors: Agonists, antagonists, expression, signaling, and adaptation to sustained stimulation.
Journal: International immunopharmacology
Published: July 16, 2019
Comparing Pathways of Bradykinin Formation in Whole Blood From Healthy Volunteers and Patients With Hereditary Angioedema Due to C1 Inhibitor Deficiency.
Journal: Frontiers in immunology
Published: June 25, 2018
The diagnosis of hereditary angioedema with C1 inhibitor deficiency: a survey of Canadian physicians and laboratories.
Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
Published: May 22, 2018
Bifunctional fusion proteins containing the sequence of the bradykinin homologue maximakinin: activities at the rat bradykinin B2 receptor.
Journal: Canadian journal of physiology and pharmacology
Published: February 08, 2018
D-Arg0-Bradykinin-Arg-Arg, a Latent Vasoactive Bradykinin B2 Receptor Agonist Metabolically Activated by Carboxypeptidases.
Journal: Frontiers in pharmacology
Published: January 05, 2018
Activation of Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonates Prodrugs by CYP1A1 as New Antimitotics Targeting Breast Cancer Cells.
Journal: Journal of medicinal chemistry
Published: May 24, 2017
Last Updated: 09/26/2026